Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
DEA advisory highlights escalating threat from fentanyl combined with cychlorphine, medetomidine, nitazenes, and xylazine—substances that resist naloxone and are driving overdose deaths across multiple states.
Kentucky launches statewide recovery housing certification program to address housing instability as primary barrier to sustained addiction recovery, setting standards for sober living facilities.
Maine Attorney General Aaron Frey announces $1 million investment from state's $230 million opioid settlement fund to strengthen Mainspring's integrated recovery support model in Kittery.
Milwaukee Public Safety and Health Committee moves forward with comprehensive plan to distribute $17.1 million in opioid settlement funds across prevention, treatment, and recovery services.
Minnesota lawmakers vote 114-15 to legalize regulated psilocybin-assisted therapy, making the state the fourth in the nation to authorize supervised psychedelic treatment for mental health and substance use disorders.
University of Alabama at Birmingham study published in JAMA Network Open finds psilocybin-assisted therapy significantly improved abstinence rates among individuals with cocaine use disorder, offering hope for a condition with no FDA-approved medications.
Mississippi secures $40.9 million from $7.4 billion Purdue-Sackler settlement, bringing total opioid recovery to over $400 million for addiction treatment and prevention programs.
Mayor Mamdani directs opioid settlement funds to create 500 peer specialist positions, expanding community-based addiction treatment and outreach across all five boroughs.
US authorities issue urgent warning to international visitors ahead of 2026 FIFA World Cup about fentanyl contamination in street drugs, as DEA reports 29% of seized pills contain lethal doses.